Poole A - Search Results

1

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing ¹⁷⁷Lu-PSMA-I&T Therapy.

John N, Pathmanandavel S, Crumbaker M, Counter W, Ho B, Yam AO, Wilson P, Niman R, Ayers M, Poole A, Hickey A, Agrawal S, Perkins G, Kallinen A, Eslick E, Stockler MR, Joshua AM, Nguyen A, Emmett L. John N, et al. Among authors: poole a. J Nucl Med. 2023 Mar;64(3):410-415. doi: 10.2967/jnumed.122.264677. Epub 2022 Sep 8. J Nucl Med. 2023. PMID: 36215568 Free article.

2

Early changes in serum type II collagen biomarkers predict radiographic progression at one year in inflammatory arthritis patients after biologic therapy.

Mullan RH, Matthews C, Bresnihan B, FitzGerald O, King L, Poole AR, Fearon U, Veale DJ. Mullan RH, et al. Among authors: poole ar. Arthritis Rheum. 2007 Sep;56(9):2919-28. doi: 10.1002/art.22843. Arthritis Rheum. 2007. PMID: 17763421 Free article.

3

Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.

Fraser A, Fearon U, Billinghurst RC, Ionescu M, Reece R, Barwick T, Emery P, Poole AR, Veale DJ. Fraser A, et al. Among authors: poole ar. Arthritis Rheum. 2003 Nov;48(11):3085-95. doi: 10.1002/art.11331. Arthritis Rheum. 2003. PMID: 14613270 Free article.

4

Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures.

Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ. Fearon U, et al. Among authors: poole ar. Arthritis Rheum. 2006 Oct;54(10):3152-62. doi: 10.1002/art.22161. Arthritis Rheum. 2006. PMID: 17009243 Free article.

5

Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U. Connolly M, et al. Among authors: poole ar. Arthritis Rheum. 2012 Apr;64(4):1035-45. doi: 10.1002/art.33455. Epub 2011 Nov 10. Arthritis Rheum. 2012. PMID: 22076945 Free article.

6

Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.

Kim TH, Stone M, Payne U, Zhang X, Ionescu M, Lobanok T, King L, Poole AR, Inman RD. Kim TH, et al. Among authors: poole ar. Arthritis Rheum. 2005 Mar;52(3):885-91. doi: 10.1002/art.20870. Arthritis Rheum. 2005. PMID: 15751093 Free article.

7

Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.

Verstappen SM, Poole AR, Ionescu M, King LE, Abrahamowicz M, Hofman DM, Bijlsma JW, Lafeber FP; Utrecht Rheumatoid Arthritis Cohort Study group (SRU). Verstappen SM, et al. Among authors: poole ar. Arthritis Res Ther. 2006;8(1):R31. doi: 10.1186/ar1882. Epub 2006 Jan 10. Arthritis Res Ther. 2006. PMID: 16507130 Free PMC article.

8

The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis.

Cahue S, Sharma L, Dunlop D, Ionescu M, Song J, Lobanok T, King L, Poole AR. Cahue S, et al. Among authors: poole ar. Osteoarthritis Cartilage. 2007 Jul;15(7):819-23. doi: 10.1016/j.joca.2007.01.016. Epub 2007 Mar 6. Osteoarthritis Cartilage. 2007. PMID: 17344068 Free PMC article.

9

Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis.

Maksymowych WP, Landewé R, Conner-Spady B, Dougados M, Mielants H, van der Tempel H, Poole AR, Wang N, van der Heijde D. Maksymowych WP, et al. Among authors: poole ar. Arthritis Rheum. 2007 Jun;56(6):1846-53. doi: 10.1002/art.22589. Arthritis Rheum. 2007. PMID: 17530713 Free article.

10

Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.

Maksymowych WP, Poole AR, Hiebert L, Webb A, Ionescu M, Lobanok T, King L, Davis JC Jr. Maksymowych WP, et al. Among authors: poole ar. J Rheumatol. 2005 Oct;32(10):1911-7. J Rheumatol. 2005. PMID: 16206346 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

957 results

Search Page